期刊文献+

重组人白细胞介素-11防治化疗所致血小板减少 被引量:9

riIL-11 for prevention and treatment of chemotherapy-induced thrombocytopenia
下载PDF
导出
摘要 化疗引起的骨髓抑制及与之相关的血小板减少症是很多化疗药物的剂量限制性毒性。重组人白细胞介素 11(rhIL 11)是目前治疗化疗导致的血小板减少症的有效药物。现综述近年来有关rhIL 11基础及临床研究方面的新进展。
出处 《国外医学(肿瘤学分册)》 2003年第6期439-440,共2页 Foreign Medical Sciences (Cancer Section)
  • 相关文献

参考文献13

  • 1Kaushansky K. Use of thrombopoietic growth factors in acute leukemia [J]. Leukemia, 2000,14(3) :505-508.
  • 2Saitoh M, Taguchi K, Momose K, et al. Recombinant human interleukin-11 improved carboplatin-induced thrombocytopenia without affecting antitumor activities in mice bearing Lewis lung carcinoma cells[J]. Cancer Chemother Pharmacol, 2002, 49(2): 161-166.
  • 3Opal SM, Jhung JW, Keith JC Jr. et al. Additive effects of human recombinant interleukin-11 and granulocyte colony-stimulating factor in experimental gram-negative sepsis[J]. Blood, 1999,93 (10): 3467-3472.
  • 4Weich NS, Fitzgerald M, Wang A. et al. Recombinant human interleukin-11 synergizes with steel factor and interleukin-3 to promote directly the early stages of murine megakaryocyte development in vitro[J]. Blood, 2000, Jan1S;95(2):503-509.
  • 5Ellis M, Zwaan F, Hedstrom U, et al. Recombinant human interleukin 11 and bacterial infection in patients with [correction of]haematological malignant disease undergoing chemotherapy: a double-blind placebo-controlled randomised trial [J]. Lancet, 2003,361(9354): 275-280.
  • 6Saitoh M, Taguchi K, Momose K. et al. Recombinant human interleukin-11 improved earboplatin-induced thrombocytopenia without affecting antitumor activities in mice bearing Lewis lung carcinoma cells. [J ]Cancer Chemother Pharmacol, 2002,49(2): 161-166.
  • 7孙晓非,管忠震,黄河,周清华,易成,张力健,朱军,李蓉,周娟,张梅,郭颖.重组人白细胞介素11预防和治疗血小板降低的临床研究报告[J].癌症,2002,21(8):892-895. 被引量:41
  • 8Reynolds CH. Clinieal effieacy of rhIL-11[J].Oncology(Huntingt),2000,14(9 Suppl 8) :32-40.
  • 9Ghalib R,Levine C,Hassan M, et al. Recombinant human interleukin-11 improves thrombocytopenia in patients with cirrhosis[J]. Hepatology, 2003,37(5): 1165-1171.
  • 10BusselJB,MukherjeeR, StoneAJ. A pilot study of rhuIL-11 treatment of refractory ITP[J].Am J Hematol, 2001,66(3): 172-177.

二级参考文献2

  • 1[1]Isaacs C,Robert NJ,Bailey FA,et al. Randomized placebo-controlled study of recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with breast cancer receiving dose-intensive cyclophosphamide and doxorubicin [J]. J Clin Oncol, 1997, 15:3368- 3377.
  • 2[2]John W, Smith H. Tolerability and side-effect profile of rhIL-11 [J]. Oncology,2000,14(9):41- 47.

共引文献40

同被引文献49

引证文献9

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部